Envisagenics is a startup based in the Netherlands, most recent round Series A, 2 tracked investors.
Envisagenics is a company headquartered in the Netherlands. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Envisagenics is an AI-driven RNA splicing therapeutics company that leverages its proprietary SpliceCore® AI platform to discover and develop novel RNA splicing therapeutics for oncology and other diseases. They partner with pharmaceutical companies to accelerate drug discovery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.